Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-22.17%
operating margin TTM
-23.88%
revenue TTM
43.49 Million
revenue per share TTM
1.02$
valuation ratios | |
|---|---|
| pe ratio | -36.89 |
| peg ratio | -2.77 |
| price to book ratio | 8.93 |
| price to sales ratio | 8.15 |
| enterprise value multiple | -41.50 |
| price fair value | 8.93 |
profitability ratios | |
|---|---|
| gross profit margin | 88.81% |
| operating profit margin | -23.88% |
| pretax profit margin | -22.17% |
| net profit margin | -22.17% |
| return on assets | -15.18% |
| return on equity | -26.29% |
| return on capital employed | -20.94% |
liquidity ratios | |
|---|---|
| current ratio | 4.29 |
| quick ratio | 4.25 |
| cash ratio | 0.96 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 34.18 |
| operating cycle | 108.29 |
| days of payables outstanding | 362.10 |
| cash conversion cycle | -253.81 |
| receivables turnover | 4.92 |
| payables turnover | 1.01 |
| inventory turnover | 10.68 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.15 |
| debt equity ratio | 0.25 |
| long term debt to capitalization | 0.18 |
| total debt to capitalization | 0.20 |
| interest coverage | -13.78 |
| cash flow to debt ratio | -0.65 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.47 |
| cash per share | 9.43 |
| operating cash flow per share | -1.27 |
| free cash flow operating cash flow ratio | 1.16 |
| cash flow coverage ratios | -0.65 |
| short term coverage ratios | -674.54 |
| capital expenditure coverage ratio | -6.29 |
Frequently Asked Questions
When was the last time Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) reported earnings?
Tarsus Pharmaceuticals, Inc. (TARS) published its most recent earnings results on 04-11-2025.
What is Tarsus Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)'s trailing twelve months ROE is -26.29%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Tarsus Pharmaceuticals, Inc. (TARS) currently has a ROA of -15.18%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TARS's net profit margin stand at?
TARS reported a profit margin of -22.17% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TARS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.29 in the most recent quarter. The quick ratio stood at 4.25, with a Debt/Eq ratio of 0.25.